Insulin-like growth factor-1 levels are associated with high comorbidity of metabolic disorders in obese subjects; a Japanese single-center, retrospective-study.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
22 11 2022
22 11 2022
Historique:
received:
08
08
2022
accepted:
01
11
2022
entrez:
23
11
2022
pubmed:
24
11
2022
medline:
26
11
2022
Statut:
epublish
Résumé
Insulin like growth factor-1 (IGF-1) plays important roles in metabolic functions, especially in adulthood. Additionally, obese subjects are reportedly predisposed to having low absolute IGF-1 levels. However, the prevalence and clinical characteristics of obese subjects with low IGF-1 levels are unknown. We examined 64 obese subjects with a body mass index (BMI) ≥ 35 kg/m
Identifiants
pubmed: 36418379
doi: 10.1038/s41598-022-23521-1
pii: 10.1038/s41598-022-23521-1
pmc: PMC9684525
doi:
Substances chimiques
Insulin-Like Growth Factor I
67763-96-6
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
20130Subventions
Organisme : Japan Society for the Promotion of Science
ID : 20H05694
Organisme : Moonshot Research and Development Program
ID : JPMJPS2023
Informations de copyright
© 2022. The Author(s).
Références
J Clin Invest. 2017 Jan 3;127(1):1-4
pubmed: 28045402
Nat Rev Endocrinol. 2018 May;14(5):285-300
pubmed: 29546874
Front Med (Lausanne). 2021 Jun 23;8:683250
pubmed: 34249975
Am J Hypertens. 2006 Dec;19(12):1206-12
pubmed: 17161764
Diabetol Int. 2021 Dec 7;13(1):33-34
pubmed: 35059240
J Clin Endocrinol Metab. 2001 Apr;86(4):1496-503
pubmed: 11297574
Growth Horm IGF Res. 2003 Aug;13(4):113-70
pubmed: 12914749
Atherosclerosis. 2009 Sep;206(1):168-72
pubmed: 19296951
Horm Res Paediatr. 2010;73(3):153-60
pubmed: 20197666
Nat Rev Endocrinol. 2013 Jun;9(6):366-376
pubmed: 23591370
J Clin Med. 2020 Aug 12;9(8):
pubmed: 32806629
PLoS One. 2015 Mar 17;10(3):e0121087
pubmed: 25782001
Nat Rev Endocrinol. 2013 Jun;9(6):346-56
pubmed: 23568441
Lancet. 2017 Dec 16;390(10113):2627-2642
pubmed: 29029897
Endocr J. 2012;59(9):771-80
pubmed: 22673406
J Clin Invest. 1994 Sep;94(3):1126-33
pubmed: 8083353
J Clin Endocrinol Metab. 2014 Nov;99(11):3933-51
pubmed: 25356808
J Clin Endocrinol Metab. 2021 Jan 23;106(2):e520-e533
pubmed: 33125080
Best Pract Res Clin Endocrinol Metab. 2015 Oct;29(5):685-700
pubmed: 26522454
J Clin Endocrinol Metab. 2011 Jun;96(6):1587-609
pubmed: 21602453
Clin Chem. 2011 Apr;57(4):555-9
pubmed: 21285256
Eur J Endocrinol. 2005 Feb;152(2):165-70
pubmed: 15745921
Nat Rev Cancer. 2004 Aug;4(8):579-91
pubmed: 15286738
Growth Horm IGF Res. 2005 Feb;15(1):19-27
pubmed: 15701568
Endocr Pract. 2019 Nov;25(11):1191-1232
pubmed: 31760824
Endocrinol Metab Clin North Am. 2020 Jun;49(2):239-250
pubmed: 32418587
Nutr Diabetes. 2022 Aug 9;12(1):38
pubmed: 35945221
Mol Metab. 2021 Oct;52:101245
pubmed: 33962049
Obes Res. 1996 Sep;4(5):471-8
pubmed: 8885212
J Atheroscler Thromb. 2018 Sep 1;25(9):846-984
pubmed: 30135334
J Transl Med. 2016 Jan 06;14:3
pubmed: 26733412
Arch Med Sci. 2017 Jun;13(4):851-863
pubmed: 28721154
Japan Med Assoc J. 2012 Jul;55(4):324-9
pubmed: 25237241
Eur J Endocrinol. 2010 Aug;163(2):233-42
pubmed: 20508082
J Clin Endocrinol Metab. 2000 Apr;85(4):1686-94
pubmed: 10770216
N Engl J Med. 2019 Jun 27;380(26):2551-2562
pubmed: 31242363
Metabolism. 1994 Mar;43(3):315-9
pubmed: 7511202
Endocr J. 1993 Feb;40(1):41-5
pubmed: 7951495
Am J Kidney Dis. 2009 Jun;53(6):982-92
pubmed: 19339088
Growth Horm IGF Res. 2014 Dec;24(6):221-6
pubmed: 25315226
J Gerontol A Biol Sci Med Sci. 2021 Jun 14;76(7):1303-1308
pubmed: 33180942
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
J Diabetes Investig. 2020 Jul;11(4):1020-1076
pubmed: 33021749
Hypertens Res. 2019 Sep;42(9):1235-1481
pubmed: 31375757